Article

A Case of Dermatomyositis-Associated Calcinosis

Hard, mobile, painless subcutaneous nodules developed in this woman who had had dermatomyositis for 20 years. The calcifications progressed during treatment with infliximab.

Heliotrope rash of dermatomyositis.

Heliotrope rash in a different patient with dermatomyositis.

Siddiqui NS, Altorok N. Images in Clinical Medicine: Diffuse Soft-Tissue Calcinosis. N Engl J Med. 2015; 373:173. July 9, 2015. DOI: 10.1056/NEJMicm1407238

 

A 50-year-old woman had been diagnosed with dermatomyositis 20 years earlier.

Treatment with methotrexate and prednisone resulted in remission of myopathy, but the patient continued to have an inflammatory skin disease.

For the last 10 years, she had progression of hard, mobile, painless subcutaneous nodules.

The presentation was consistent with dermatomyositis-associated calcinosis, which can also be seen in disorders such as systemic sclerosis (scleroderma).

The calcifications progressed during treatment with infliximab.

 

Related Videos
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
© 2024 MJH Life Sciences

All rights reserved.